$Esperion Therapeutics (ESPR.US)$Esperion Partner HLS Therapeutics Announces Approval of NILEMDO® for the Reduction of LDL-Cholesterol in Canadians at Risk of Cardiovascular Disease | Esperion Therapeutics, Inc.

Canadian approval has been given for ESPR. They will start selling the cholesterol medication (bempedoic acid) there from Q2 2026, which should improve earnings reports for the 2nd half of 2026 hopefully.

FOR IMMEDIATE RELEASE
November 17, 2025
Two Stocks With Significant Upside Potential as Major Catalysts Approach: Esperion (ESPR) $Esperion Therapeutics (ESPR.US)$ and Nano Dimension (NNDM) $Nano Dimension (NNDM.US)$  The Roaring Lion.
New York — November 17, 2025 — As markets enter a week filled with major corporate catalysts, two companies—Esperion Therapeutics (NASDAQ: ESPR) and Nano Dimension (NASDAQ: NNDM)—stand out for their compelling setups and notable v...

$Esperion Therapeutics (ESPR.US)$ H.C Wainwright likes Esperion. with firm $16 PT. I won't be surprised if that projection will be proven as correct along 2026. it looks like that's Esperion's time to shine.

$Esperion Therapeutics (ESPR.US)$ 🔥🔥🔥

$Xeris Pharmaceuticals (XERS.US)$ Will need to raise higher quite soon, I believe.

Hi Mooers!🎉
What an exciting to the second week of the Global Paper Trading Challenge! With markets moving fast, the competition is heating up—and now is the perfect time to jump in if you haven’t already.  Join the Challenge Now>>
🎁Your limited-time bonus awaits!
To thank our amazing mooers, we're dropping a FREE, NO-STRINGS-ATTACHED Bonus!
🗓️️ Mark your calendars!
From October 28 at 12:00 PM ET to ...

$Esperion Therapeutics (ESPR.US)$ So blessed to have held this stock and have not panic sold it. Only up from here!!

$Esperion Therapeutics (ESPR.US)$
!!